BioCentury
ARTICLE | Clinical News

Cangrelor regulatory update

January 6, 2014 8:00 AM UTC

On Dec. 23, 2013, The Medicines Co. said EMA accepted for review an MAA for IV cangrelor, an antiplatelet therapy in development to prevent platelet activation and aggregation when oral therapy is not...